🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This will be a randomised, crossover, double-blind, double-dummy, active-co...
Status
Completed
Location
Clinical Research Services Turku CRST
Start Date
2016-04-08
Trial ID
NCT02764125
Treatments Being Tested
20 patients with idiopathic Parkinson's disease, who are planned to undergo...
Status
Unknown
Location
Multiple Locations
Start Date
2022-10
Trial ID
NCT05579379
The purpose of this study is to assess the safety and bioequivalence of a s...
Status
Completed
Location
Novartis Investigative Site
Start Date
2006-06
Trial ID
NCT00415844
Treatments Being Tested
Addiction to methamphetamine is a serious health problem. There are no medi...
Status
Completed
Location
Oregon Health & Science University
Start Date
2014-06
Trial ID
NCT02058966
Treatments Being Tested
To investigate the effect of rising oral single-doses of BIA 6-512 (25 mg, ...
Status
Completed
Location
Human Pharmacology Unit (UFH)
Start Date
2004-11-03
Trial ID
NCT03091868
Treatments Being Tested
In this trial, 36 healthy subjects are planned to be enrolled in postprandi...
Status
Unknown
Location
Multiple Locations
Start Date
2023-12-20
Trial ID
NCT06180720
This observational study is designed to collect data on the use of the drug...
Status
Active Not Recruiting
Location
Universitätsklinik für Neurologie, Medizinische Universität Graz
Start Date
2021-07-06
Trial ID
NCT05043103
Treatments Being Tested
The purpose of this study is to assess the safety and bioequivalence of a s...
Status
Completed
Location
Novartis Investigative Site
Start Date
2006-05
Trial ID
NCT00415740
Treatments Being Tested
Phase I open, randomized cross-over pharmacokinetic study....
Status
Completed
Location
Clinical Research Services Turku CRST
Start Date
2015-08
Trial ID
NCT02554734
Treatments Being Tested
The purpose of this study is to confirm that the dose levels and dosing fre...
Status
Completed
Location
Phase I Unit, Orion Pharma
Start Date
2009-12
Trial ID
NCT01070628
Treatments Being Tested